Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2023
    In:  Cancer Research Vol. 83, No. 7_Supplement ( 2023-04-04), p. 5402-5402
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 83, No. 7_Supplement ( 2023-04-04), p. 5402-5402
    Abstract: IC50, Emax, and AUC values are commonly used to assess susceptibility for a given therapeutic candidate but are subject to the number of cell divisions for a given in vitro model. When comparing multiple in vitro models and especially patient-derived models such as patient-derived tumor organoids, the degree of intrinsic cell proliferation or doubling time substantially differs and therefore limits conventional metrics as above. Furthermore, assays that directly measure cellular viability can oftentimes overlook therapeutic agents that have cytostatic, versus cytotoxic mechanisms of action and require assays with similar sensitivity and precision to account for this phenotype. Finally, terminal endpoint assays can require tedious temporal optimization to capture the full dynamic range of a given therapeutic which makes cross-therapeutic and cross-model comparisons difficult to interpret. An assay that incorporates these multiple features and in vitro specific doubling time would lead to highly accurate measurements of drug effects and allow the calculation of growth-adjusted IC50 values i.e. GI50 values. We, therefore, sought to develop a computer vision model that utilizes label-free longitudinal light microscopy images as input to report the total number of nuclei present within a given experimental well, allowing for the monitoring of cell division and any cytostatic effects. To train the neural network, we use Hoechst-stained images as our ground truth. The model used is an extension of the Regularized Conditional Adversarial Network (PMID: 34320344). It takes as input Brightfield images along with the registered Hoescht stained wells. The label for each well is obtained using commercial image processing software to count the total number of nuclei present in each well from the Hoescht stained channel. The model was trained to predict the virtually stained Hoescht well for every Brightfield, as well as the aggregate nuclei count for all organoids present inside the well. The model was trained on 29000 individual sites across 9 distinct cancer types. Five experiments were conducted during training to test for bit depth and tonality effects of the input training data. Inference on 9240 images showed a pearsonR score of 0.81 on the best-performing model. Results show that the model performs well and can be applied in real-time using only experimental data to correct for differing cell division rates and measure cytostatic phenotypes all while using simple light microscopy. The tool will enable cross-comparison of different therapeutic MoAs as well as enable cross-cancer type/indication comparison for a therapeutic in development to inform early development clinical strategy. Citation Format: Madhavi Kannan, Brian Larsen, Chi-Sing Ho, Jagadish Venkataraman, Martin Stumpe, Ameen Salahudeen. Using computer vision to resolve proliferative dynamics within therapeutic responses in large scale screens of patient derived models. [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 5402.
    Type of Medium: Online Resource
    ISSN: 1538-7445
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2023
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    IOP Publishing ; 2021
    In:  IOP Conference Series: Materials Science and Engineering Vol. 1059, No. 1 ( 2021-02-01), p. 012044-
    In: IOP Conference Series: Materials Science and Engineering, IOP Publishing, Vol. 1059, No. 1 ( 2021-02-01), p. 012044-
    Abstract: Piston pins play a crucial part for providing support to the connecting rod which plays a pivotal role in functioning of the automobile. The current work focusses on identifying the factors which affect the inner bore diameter for piston pins during the boring process and also finding an optimal setup which can reduce tool life. In order to identify the parameters which, have an effect, factors such as speed, feed and depth of cut were considered and a full factorial design of experiments were conducted with 3 replicates. The response variable used while conducting include mean inner diameter and range. The experiments were conducted using randomization principle and experimental conditions were run according to random number generator using Minitab software. Analysis of variance (ANOVA) was conducted using Minitab and based on the ANOVA results, main effects and interaction plot, optimal parameters values were chosen which would provide optimal inner bore diameters. In addition, optimal parameters where accordingly chosen which would provide longer tool life.
    Type of Medium: Online Resource
    ISSN: 1757-8981 , 1757-899X
    Language: Unknown
    Publisher: IOP Publishing
    Publication Date: 2021
    detail.hit.zdb_id: 2506501-4
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    Frontiers Media SA ; 2022
    In:  Frontiers in Cardiovascular Medicine Vol. 9 ( 2022-10-6)
    In: Frontiers in Cardiovascular Medicine, Frontiers Media SA, Vol. 9 ( 2022-10-6)
    Abstract: Calcification of large arteries is a high-risk factor in the development of cardiovascular diseases, however, due to the lack of routine monitoring, the pathology remains severely under-diagnosed and prevalence in the general population is not known. We have developed a set of machine learning methods to quantitate levels of abdominal aortic calcification (AAC) in the UK Biobank imaging cohort and carried out the largest to-date analysis of genetic, biochemical, and epidemiological risk factors associated with the pathology. In a genetic association study, we identified three novel loci associated with AAC ( FGF9, NAV9 , and APOE ), and replicated a previously reported association at the TWIST1/HDAC9 locus. We find that AAC is a highly prevalent pathology, with ~ 1 in 10 adults above the age of 40 showing significant levels of hydroxyapatite build-up (Kauppila score & gt; 3). Presentation of AAC was strongly predictive of future cardiovascular events including stenosis of precerebral arteries (HR~1.5), myocardial infarction (HR~1.3), ischemic heart disease (HR~1.3), as well as other diseases such as chronic obstructive pulmonary disease (HR~1.3). Significantly, we find that the risk for myocardial infarction from elevated AAC (HR ~1.4) was comparable to the risk of hypercholesterolemia (HR~1.4), yet most people who develop AAC are not hypercholesterolemic. Furthermore, the overwhelming majority (98%) of individuals who develop pathology do so in the absence of known pre-existing risk conditions such as chronic kidney disease and diabetes (0.6% and 2.7% respectively). Our findings indicate that despite the high cardiovascular risk, calcification of large arteries remains a largely under-diagnosed lethal condition, and there is a clear need for increased awareness and monitoring of the pathology in the general population.
    Type of Medium: Online Resource
    ISSN: 2297-055X
    Language: Unknown
    Publisher: Frontiers Media SA
    Publication Date: 2022
    detail.hit.zdb_id: 2781496-8
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 83, No. 7_Supplement ( 2023-04-04), p. 4692-4692
    Abstract: Next-generation sequencing (NGS) of bulk cell populations is a useful and ubiquitous tool for the molecular characterization of clinical tumor samples. Bulk NGS reveals transcript abundance within a tumor sample and can further infer cell populations via deconvolution algorithms (PMID:31570899). However, it can’t ascribe the cellular context for a given gene’s expression or elucidate the spatial organization of tumor microenvironments. These additional features are critical to our understanding of tumor biology and are key to the development of immuno-oncology therapeutics. Spatial Transcriptomics (ST) is an emerging technology that characterizes gene expression within the spatial context of tissue. ST data can be generated directly from archival formalin fixed paraffin embedded samples, enabling the study of spatial gene expression in real-world clinical settings. We have studied a dataset comprising 6 samples from non-small cell lung cancer (NSCLC) patients and 1 core needle biopsy from a tumor of unknown origin. We used the 10X Visium CytAssist platform to generate ST data and additionally generated paired bulk RNAseq data. To test the interassay reliability of CytAssist on archival FFPE tissue sections, we compared ST results across 3 sample preparation conditions. We further studied the state of the tumor microenvironment by applying state-of-the-art computational approaches to deconvolve immune cell populations and produce super-resolution ST maps, validated using multiplex immunofluorescence (IF) via CODEX (PMID:30078711). We find key quality control metrics and spatial biomarkers are consistent across all 3 sample preparation conditions. When comparing deconvolution results between bulk and spatially-resolved methods we observe modest correlations for many cell types despite differences in sample preparation, supporting the idea that bulk and spatial samples contain complementary transcriptomic information. However, within samples, we find many of the correlations observed in bulk do not show strong spatial correlation. These comparisons indicate the importance of considering spatial context when studying the tumor immune microenvironment. Finally, we find an agreement between super-resolution ST and multiplex IF across key spatial biomarkers. These results demonstrate clinical archival FFPE samples yield high interassay reliability via the CytAssist platform. Results were consistent through 3 different H & E staining protocols and findings were consistent when superresolution deconvolution was utilized which further strongly correlated with high-resolution multiplex IF. Our findings demonstrate the feasibility and translational utility of ST to discover spatial signatures and the cellular context in retrospective clinical cohorts to empower discovery and translational efforts in precision oncology and therapeutic development. Citation Format: Mario G. Rosasco, Chi-Sing Ho, Tianyou Luo, Michelle M. Stein, Luca Lonini, Martin C. Stumpe, Jagadish Venkataraman, Sonal Khare, Ameen A. Salahudeen. Comparison of interassay similarity and cellular deconvolution in spatial transcriptomics data using Visum CytAssist. [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 4692.
    Type of Medium: Online Resource
    ISSN: 1538-7445
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2023
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    In: Circulation, Ovid Technologies (Wolters Kluwer Health), Vol. 146, No. Suppl_1 ( 2022-11-08)
    Abstract: Introduction: Cardiac amyloidosis (CA) is a common cause of progressive heart failure. New therapies can improve outcomes but most CA patients remain undiagnosed and untreated. Machine learning models deployed on electronic health record (EHR) data may be able to find patients with undiagnosed CA. To date, most models have focused on identification of undiagnosed amyloid from uncensored data modalities (Fig 1). Hypothesis: We hypothesized that lack of post-diagnosis censoring when training CA models leads to poor performance in predicting patients with undiagnosed CA whereas training with appropriate time censoring improves performance. Methods: We used 41 EHR features (demographics, labs, electrocardiogram/echocardiography measurements, vitals) to train a boosted decision tree model with and without time censoring. This was applied to 112 patients with confirmed CA and 22,400 controls matched on age, sex, encounter frequency and timespan of EHR. We also compared our findings to a web-based CA algorithm that was publicly available in 2020. Results: The EHR algorithm had modestly higher performance on at-risk, time-censored patients when trained with and without time censoring (area under the receiver operating characteristic curve (AUROC) 0.84±0.09 vs 0.79±0.07). Testing on temporally uncensored data showed higher performance (AUROC: 0.91±0.05) which may be unrepresentative of deployment scenarios where post-diagnostic features are unavailable for model use. The publicly available algorithm demonstrated a similar trend when tested on uncensored data (AUROC: 0.67±0.03) as compared to an appropriately censored feature set (AUROC: 0.54±0.04). Conclusions: EHR algorithms can be trained to find patients with high risk of undiagnosed cardiac amyloidosis. These models should be evaluated on temporally censored data so that post-diagnostic features do not artificially inflate performance estimates and negatively impact real-world deployment.
    Type of Medium: Online Resource
    ISSN: 0009-7322 , 1524-4539
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2022
    detail.hit.zdb_id: 1466401-X
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    Institute of Electrical and Electronics Engineers (IEEE) ; 2007
    In:  IEEE Transactions on Communications Vol. 55, No. 10 ( 2007-10), p. 1951-1962
    In: IEEE Transactions on Communications, Institute of Electrical and Electronics Engineers (IEEE), Vol. 55, No. 10 ( 2007-10), p. 1951-1962
    Type of Medium: Online Resource
    ISSN: 0090-6778
    RVK:
    RVK:
    Language: Unknown
    Publisher: Institute of Electrical and Electronics Engineers (IEEE)
    Publication Date: 2007
    detail.hit.zdb_id: 2028235-7
    detail.hit.zdb_id: 121987-X
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    In: Cell Reports, Elsevier BV, Vol. 36, No. 4 ( 2021-07), p. 109429-
    Type of Medium: Online Resource
    ISSN: 2211-1247
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2021
    detail.hit.zdb_id: 2649101-1
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    In: Journal for ImmunoTherapy of Cancer, BMJ, Vol. 9, No. Suppl 2 ( 2021-11), p. A70-A70
    Abstract: Cell engager and adoptive cell therapeutics have emerged as efficacious and durable treatments in patients with B-cell malignancies. Though many analogous strategies are under development in solid tumors, none have received approval. Preclinical development of these therapies requires cell labeling of immortalized cell lines and/or primary expanded T cells to distinguish target and effector cells. However, cell engager and adoptive cell therapies have had limited evidence of reproducibility in primary patient-derived models such as tumor organoid cultures thus far. Here, we build upon our tumor organoid platform 1 to measure organoid specific responses to these therapies. Utilizing machine vision coupled with time-lapse-microscopy, we obtain multiparameter kinetic readouts of patient-derived tumor organoid cell killing and allogeneic MHC-matched primary peripheral blood mononuclear cells (PBMCs). Methods The patient-derived tumor organoids were co-cultured with PBMCs in the presence of engagers/activators and vital dyes and incubated for 96 hrs. Cell death was measured by quantifying the caspase 3/7 vital dye pixel intensities at different time points using high throughput imaging. As a first step, a fully convolutional neural network was trained to segment out organoids from brightfield images comprised of organoids, immune cells and potential background artifacts. This segmentation mask was then transferred over to registered caspase 3/7 images to quantify tumor cell specific phenotypes in a rapid and automated manner. Results The time-lapse imaging assay allowed for both the tracking of the organoid growth over time as well as the quantification of the kinetics of engagers/activators in comparison to controls resulting in accurate and precise technical reproducibility. Further, this assay allowed for the co-localization of the organoids and the immune cells over time, thus, enabling a spatiotemporal summary of dose dependent efficacy of candidate therapeutics. Conclusions We demonstrate the scalability and throughput of a machine vision tumor organoid immune co-culture platform across multiple unique patient-derived tumor organoid lines bearing a target of interest, enabling future discovery of biomarkers of therapeutic response and resistance. Reference Larsen B, Kannan M, Langer LF, Khan AA, Salahudeen AA, A pan-cancer organoid platform for precision medicine. Cell Reports 2021; 36 :109429
    Type of Medium: Online Resource
    ISSN: 2051-1426
    Language: English
    Publisher: BMJ
    Publication Date: 2021
    detail.hit.zdb_id: 2719863-7
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages